QQ客服 官方微博 反馈留言

	Blocking ROR1 enhances the roles of erlotinib in lung adenocarcinoma cell lines
	Wang, Hui-Li[1]; Liu, Yan-Chun[2]; Long, Ming-Peng[1]; Zheng, Chuan[1]; Yang, Jia-Hui[1]
	2019
卷号	18期号:3页码:2977-2984
URL标识	查看原文
WOS记录号	WOS:000487675500101
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4716684
专题	成都中医药大学
作者单位	1.[1]Chengdu Univ Tradit Chinese Med, Sch Basic Med, 1166 Liutai Ave, Chengdu 611137, Sichuan, Peoples R China 2.[2]Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Yunnan, Peoples R China
推荐引用方式 GB/T 7714	Wang, Hui-Li[1],Liu, Yan-Chun[2],Long, Ming-Peng[1],et al. Blocking ROR1 enhances the roles of erlotinib in lung adenocarcinoma cell lines[J],2019,18(3):2977-2984.
APA	Wang, Hui-Li[1],Liu, Yan-Chun[2],Long, Ming-Peng[1],Zheng, Chuan[1],&Yang, Jia-Hui[1].(2019).Blocking ROR1 enhances the roles of erlotinib in lung adenocarcinoma cell lines.,18(3),2977-2984.
MLA	Wang, Hui-Li[1],et al."Blocking ROR1 enhances the roles of erlotinib in lung adenocarcinoma cell lines".18.3(2019):2977-2984.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。